	Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study. Br J Cancer Yang K, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Jansen L, Brenner H, Arndt V. PMID: 42129336 [PubMed - as supplied by publisher]
	Metaheuristic optimization of deep CNNs for multi-class diagnosis of cervical cancer and lymphoma. Sci Rep Abdelhay EH, Elgamily KM, Badr WOE. PMID: 42129228 [PubMed - indexed for MEDLINE]
	Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial. Nat Commun Veneziani AC, Lheureux S, Millar DG, Dhani N, Colombo I, Madariaga A, Soberanis Pina P, Atale S, Chan YL, Lee J, Ramsahai J, Quintos J, Wang L, Li X, Bowering V, Ohashi P, Wang B, Oza AM. PMID: 42129168 [PubMed - as supplied by publisher]
	Providing information to prepare breast cancer patients for their surgical consultation: barriers and recommendations (an analysis from Alliance A231701CD). Support Care Cancer Saucke MC, Jacobson N, Chow S, McKinney G, Neuman HB. PMID: 42128956 [PubMed - indexed for MEDLINE]
	Mucinous carcinoma of the breast: morphological spectrum, diagnostic pitfalls and classification challenges. J Clin Pathol Rakha EA, Wazwaz B, Fox SB. PMID: 42128624 [PubMed - as supplied by publisher]
	Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10). BMJ Open Ozaki Y, Koyama S, Morita S, Miyashita M, Tokuda E, Shimoi T, Fukuoka M, Masuda H, Takano Y, Shibata N, Yoshinami T, Murakami A, Tamaki K, Ishiguro H, Saji S, Miwa A, Matsunaga J, Zheng Y, Nishikawa H, Masuda N. PMID: 42128502 [PubMed - indexed for MEDLINE]
	Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors. Drug Resist Updat Ye M, Wu Y, Chen Z, Zhai Q, Li L, Yan Z, Li M, Gu C, Yang W, Liao S, Meng Y. PMID: 42128460 [PubMed - as supplied by publisher]
	Extracellular vesicle-derived protein biomarkers for breast Cancer diagnosis: a systematic review, meta-analysis, and umbrella review. Clin Chim Acta Parron-Carreño T, Nievas-Soriano BJ, Lozano-Paniagua D, Murillo-Cancho AF, Cristobal-Cañadas D. PMID: 42128323 [PubMed - as supplied by publisher]
	Neoantigen-driven personalized vaccines for breast cancer: Platforms, nano-delivery systems, and combination strategies. Biochim Biophys Acta Rev Cancer Liu X, Liu J, Chao T, Liu Q, Xiong H. PMID: 42128147 [PubMed - as supplied by publisher]
	From barrier invasion to niche formation: mechanisms and therapies in breast cancer brain metastases. J Adv Res Yang H, Li X, Xu S, Zhao Y, Cai S, Feng D, Yao Y. PMID: 42128089 [PubMed - as supplied by publisher]
	Assessing platinum response in first-line advanced ovarian cancer: clinical implications and future directions. Int J Gynecol Cancer Barretina-Ginesta MP, Redondo A, Cortés-Salgado A, Madariaga A, Pérez-Mies B, Sancho L, Valls-Masot L, Domínguez M, González-Martín A. PMID: 42127859 [PubMed - as supplied by publisher]
	Taxane-Induced Peripheral Neuropathy-Driven Treatment Modification and Pathologic Complete Response After Neoadjuvant TCHP in HER2-Positive Breast Cancer: A Retrospective Cohort Study. Clin Breast Cancer Negreanu RA, Verga N, G. PMID: 42127583 [PubMed - as supplied by publisher]
	Baseline clinical and laboratory profiles at breast cancer diagnosis in Tanzania: differences by HIV status. Breast Nyagabona SK, Paciorek A, Pallangyo A, Pallangyo CK, Jackie Wang CC, Kahesa C, Zhang L, Van Loon K, Sunguya B, Mmbaga EJ. PMID: 42127480 [PubMed - as supplied by publisher]
	Risk factors of ovarian cancer: a systematic review and meta-analysis of Mendelian randomiation studies. J Public Health (Oxf) Yalew M, Lumsden AL, Mulugeta A, Madakkatel I, Lee SH, Oehler MK, Mäenpää J, Hyppönen E. PMID: 42127414 [PubMed - as supplied by publisher]
	Optimizing Breast Cancer Survivorship: Addressing Lifestyle, Weight Management, and Psychological Health. Am Soc Clin Oncol Educ Book Hundal J, Chen J, Russell KB, Carfang L, Bedeau AJ, Giguère L, Ouattara MM, Sehabi GS, Lebel S, Shen S, Comander A. PMID: 42127339 [PubMed - indexed for MEDLINE]
	From Scaffold to Therapy: Benzimidazole Pharmacophore Evolution in Breast Cancer Research. Chem Biodivers Kaur A, Singh G. PMID: 42127228 [PubMed - indexed for MEDLINE]
	Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative. J Obstet Gynaecol Waldman R, DeFrancesco M, Feltz J, Welling D, Neiman W, Smith E, Schneider L, Lenz L, Johansen Taber K, Adkins R. PMID: 42127212 [PubMed - indexed for MEDLINE]
	Social disparities in the frequency and severity of triple-negative breast cancer at diagnosis in a university hospital in Paris, France: confronting race and ethnic blindness. PLoS One Chauvin P, Huet T, Gligorov J, Sargent C. PMID: 42127126 [PubMed - indexed for MEDLINE]
	Feasibility of the Xemio app for breast cancer survivors in a clinical setting: Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL). PLoS One Fuentes-Expósito MA, Frid S, Muñoz-Mateu M, Sisó-Almirall A, Armayones Ruiz M, Grau-Corral I. PMID: 42127092 [PubMed - indexed for MEDLINE]
	Artifacts at Breast MRI: Appearances and Solutions. Radiographics Quispe Villca F, Pesce KA, Choque Leniz G, Lee MV, Chico MJ, Martínez de Vega V, García AT, Luna G. PMID: 42126967 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 328619

Page 1 of 16431



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy